Correlation Between HUTCHMED DRC and Elite Pharma
Can any of the company-specific risk be diversified away by investing in both HUTCHMED DRC and Elite Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HUTCHMED DRC and Elite Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HUTCHMED DRC and Elite Pharma, you can compare the effects of market volatilities on HUTCHMED DRC and Elite Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HUTCHMED DRC with a short position of Elite Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of HUTCHMED DRC and Elite Pharma.
Diversification Opportunities for HUTCHMED DRC and Elite Pharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between HUTCHMED and Elite is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding HUTCHMED DRC and Elite Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elite Pharma and HUTCHMED DRC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HUTCHMED DRC are associated (or correlated) with Elite Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elite Pharma has no effect on the direction of HUTCHMED DRC i.e., HUTCHMED DRC and Elite Pharma go up and down completely randomly.
Pair Corralation between HUTCHMED DRC and Elite Pharma
If you would invest 3.73 in Elite Pharma on October 5, 2024 and sell it today you would earn a total of 0.00 from holding Elite Pharma or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 4.76% |
Values | Daily Returns |
HUTCHMED DRC vs. Elite Pharma
Performance |
Timeline |
HUTCHMED DRC |
Elite Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
HUTCHMED DRC and Elite Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with HUTCHMED DRC and Elite Pharma
The main advantage of trading using opposite HUTCHMED DRC and Elite Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HUTCHMED DRC position performs unexpectedly, Elite Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elite Pharma will offset losses from the drop in Elite Pharma's long position.HUTCHMED DRC vs. ANI Pharmaceuticals | HUTCHMED DRC vs. Phibro Animal Health | HUTCHMED DRC vs. Prestige Brand Holdings | HUTCHMED DRC vs. Pacira BioSciences, |
Elite Pharma vs. Amarantus Bioscience Holdings | Elite Pharma vs. Intelgenx Technologs | Elite Pharma vs. Cytosorbents Crp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |